The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
P-MCP treatment in non-metastatic biochemically relapsed prostate cancer (BRPC-M0): Final long-term results of a prospective phase II study.
 
Daniel Keizman
No Relationships to Disclose
 
Moshe A. Frenkel
No Relationships to Disclose
 
Avivit Peer
No Relationships to Disclose
 
Igal Kushnir
Stock and Other Ownership Interests - Teva
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen; Medison; MSD
Consulting or Advisory Role - MSD
 
Eli Rosenbaum
Stock and Other Ownership Interests - Brainsway; Conergent
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; MSD Oncology; Teva
Speakers' Bureau - MSD Oncology
 
David Leonid Sarid
No Relationships to Disclose
 
Ilan Leibovitch
No Relationships to Disclose
 
Roy Mano
No Relationships to Disclose
 
Ofer Yossepowitch
No Relationships to Disclose
 
David Margel
No Relationships to Disclose
 
Ido Wolf
Honoraria - Beyond Air
Consulting or Advisory Role - AstraZeneca/MedImmune; BMS; Gilead Sciences; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca/MedImmune; BMS; Merck Serono; MSD; Novartis; Roche
Research Funding - Roche (Inst)
 
Ravit Geva
Leadership - Pyxis
Stock and Other Ownership Interests - BOL Pharma; Pyxis
Honoraria - BMS; Janssen; Medison; Merck; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BOL Pharma; JNJ; MSD; Rhenium Medical; Roche
Travel, Accommodations, Expenses - Medison; Takeda (Inst)
 
Keren Rouvinov
No Relationships to Disclose
 
Hadas Dresler
No Relationships to Disclose
 
Isaac Eliaz
Stock and Other Ownership Interests - Amitabha
Patents, Royalties, Other Intellectual Property - US Patents: #10555966, #10213462; US Patents: #9549953, #9649329, #9427449, #8916541, #8764695, #8426567, #7452871, #7026302, #6462029, #6274566.